Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib with Radiotherapy in Non-Metastatic Prostate Cancer
NCT00239291Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in prostate cancer (PCa), sponsored by AstraZeneca. Started Jan 2003; status: completed.
02
Drugs
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00239291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239291.